URL has been copied successfully!
“Don’t wait. Choose to be informed.”
That’s the call to action that patients will find on the site for digital health company Everlywell, which has offered at-home lab tests directly to consumers for a decade. But last week, it wasn’t marketing a prick to measure blood glucose or screen for celiac disease: It was launching one of a new generation of AI-based risk prediction algorithms for medical images.
For $249 in cash, eligible patients can now come to the site, share a recent mammogram, and receive a prediction of their five-year breast cancer risk. It’s generated by an AI algorithm called Clairity Breast, which received de novo authorization from the Food and Drug Administration last May.
Please follow us:
